Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk

Abstract Obesity is a well-established risk factor for human cancer, yet the underlying mechanisms remain elusive. Immune dysfunction is commonly associated with obesity but whether compromised immune surveillance contributes to cancer susceptibility in individuals with obesity is unclear. Here we u...

Full description

Bibliographic Details
Main Authors: Alexander Piening, Emily Ebert, Carter Gottlieb, Niloufar Khojandi, Lindsey M. Kuehm, Stella G. Hoft, Kelly D. Pyles, Kyle S. McCommis, Richard J. DiPaolo, Stephen T. Ferris, Elise Alspach, Ryan M. Teague
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-47359-5
_version_ 1797219760948117504
author Alexander Piening
Emily Ebert
Carter Gottlieb
Niloufar Khojandi
Lindsey M. Kuehm
Stella G. Hoft
Kelly D. Pyles
Kyle S. McCommis
Richard J. DiPaolo
Stephen T. Ferris
Elise Alspach
Ryan M. Teague
author_facet Alexander Piening
Emily Ebert
Carter Gottlieb
Niloufar Khojandi
Lindsey M. Kuehm
Stella G. Hoft
Kelly D. Pyles
Kyle S. McCommis
Richard J. DiPaolo
Stephen T. Ferris
Elise Alspach
Ryan M. Teague
author_sort Alexander Piening
collection DOAJ
description Abstract Obesity is a well-established risk factor for human cancer, yet the underlying mechanisms remain elusive. Immune dysfunction is commonly associated with obesity but whether compromised immune surveillance contributes to cancer susceptibility in individuals with obesity is unclear. Here we use a mouse model of diet-induced obesity to investigate tumor-infiltrating CD8 + T cell responses in lean, obese, and previously obese hosts that lost weight through either dietary restriction or treatment with semaglutide. While both strategies reduce body mass, only dietary intervention restores T cell function and improves responses to immunotherapy. In mice exposed to a chemical carcinogen, obesity-related immune dysfunction leads to higher incidence of sarcoma development. However, impaired immunoediting in the obese environment enhances tumor immunogenicity, making the malignancies highly sensitive to immunotherapy. These findings offer insight into the complex interplay between obesity, immunity and cancer, and provide explanation for the obesity paradox observed in clinical immunotherapy settings.
first_indexed 2024-04-24T12:38:46Z
format Article
id doaj.art-cd1f556956cf44109479901a6087aca1
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-24T12:38:46Z
publishDate 2024-04-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-cd1f556956cf44109479901a6087aca12024-04-07T11:22:52ZengNature PortfolioNature Communications2041-17232024-04-0115111210.1038/s41467-024-47359-5Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer riskAlexander Piening0Emily Ebert1Carter Gottlieb2Niloufar Khojandi3Lindsey M. Kuehm4Stella G. Hoft5Kelly D. Pyles6Kyle S. McCommis7Richard J. DiPaolo8Stephen T. Ferris9Elise Alspach10Ryan M. Teague11Department of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Biochemistry and Molecular Biology, Saint Louis University School of MedicineDepartment of Biochemistry and Molecular Biology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineDepartment of Molecular Microbiology and Immunology, Saint Louis University School of MedicineAbstract Obesity is a well-established risk factor for human cancer, yet the underlying mechanisms remain elusive. Immune dysfunction is commonly associated with obesity but whether compromised immune surveillance contributes to cancer susceptibility in individuals with obesity is unclear. Here we use a mouse model of diet-induced obesity to investigate tumor-infiltrating CD8 + T cell responses in lean, obese, and previously obese hosts that lost weight through either dietary restriction or treatment with semaglutide. While both strategies reduce body mass, only dietary intervention restores T cell function and improves responses to immunotherapy. In mice exposed to a chemical carcinogen, obesity-related immune dysfunction leads to higher incidence of sarcoma development. However, impaired immunoediting in the obese environment enhances tumor immunogenicity, making the malignancies highly sensitive to immunotherapy. These findings offer insight into the complex interplay between obesity, immunity and cancer, and provide explanation for the obesity paradox observed in clinical immunotherapy settings.https://doi.org/10.1038/s41467-024-47359-5
spellingShingle Alexander Piening
Emily Ebert
Carter Gottlieb
Niloufar Khojandi
Lindsey M. Kuehm
Stella G. Hoft
Kelly D. Pyles
Kyle S. McCommis
Richard J. DiPaolo
Stephen T. Ferris
Elise Alspach
Ryan M. Teague
Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk
Nature Communications
title Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk
title_full Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk
title_fullStr Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk
title_full_unstemmed Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk
title_short Obesity-related T cell dysfunction impairs immunosurveillance and increases cancer risk
title_sort obesity related t cell dysfunction impairs immunosurveillance and increases cancer risk
url https://doi.org/10.1038/s41467-024-47359-5
work_keys_str_mv AT alexanderpiening obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT emilyebert obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT cartergottlieb obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT niloufarkhojandi obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT lindseymkuehm obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT stellaghoft obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT kellydpyles obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT kylesmccommis obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT richardjdipaolo obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT stephentferris obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT elisealspach obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk
AT ryanmteague obesityrelatedtcelldysfunctionimpairsimmunosurveillanceandincreasescancerrisk